Abstract:Background: Inherited medullary thyroid carcinoma (MTC) is primarily caused by RET mutations that are commonly localized in exons 5, 8, 10, 11, and 13-16. In this study, we report pedigrees for individuals with MTC that harbor a germline S409Y variant within exon 6 of the RET proto-oncogene. Methods: Targeted sequencing was used to diagnose four apparently sporadic MTC index cases carrying the germline RET S409Y (c.1226 C>A) variant. Subsequently, 27 relatives of these individuals underwent clinical and genetic assessments and/or thyroid surgery. Furthermore, in silico analyses and in vitro assays were performed to predict or verify the potential oncogenic activity of the S409Y variant. Results: Overall, 15 of 31 participants were found to carry the RET S409Y variant. Of these, 6 presented with isolated MTC (mean age 50.2 years; range 41-75 years), of which 3 presented with neck lymph node metastases and 2 presented with distant liver or lung metastases. Among the remaining 9 carriers, 3 (mean age 56 years; range 41-76 years) had elevated serum calcium-stimulated calcitonin (sCtn) or concurrent marginally elevated serum calcitonin (Ctn) levels, whereas the other 6 (mean age 37.5 years; range 14-52 years) exhibited typical Ctn/sCtn levels (p < 0.05). None of the 15 carriers in these 4 families presented clinical evidence of pheochromocytoma, hyperparathyroidism, or Hirschsprung's disease. In silico analyses revealed that S409Y was a "possibly damaging" mutation that could affect the RET protein inter-domain interface. An in vitro assay revealed that the phosphorylation level of RET tyrosine 905 was relatively higher in the RET S409Y mutant than in wild-type (WT) RET. Moreover, transfection of HEK 293 cells with S409Y enhanced the phosphorylation activity of AKT, ERK pathways, and it increased cell proliferation compared with WT RET, but to a lesser degree than that for the RET C618Y and C634Y mutations. Conclusions: This study demonstrates that the novel germline RET S409Y variant is likely pathogenic and is associated with lower penetrance of MTC than that for the C618Y and C634Y mutations. Individuals with S409Y should be managed using a personalized approach, and additionally, "at-risk" family members should be evaluated. Additional studies are needed to elucidate the correlation between the S409Y mutation and multiple endocrine neoplasia type 2-specific tumors.

Ret Mutational Spectrum In Hirschsprung Disease: Evaluation Of 601 Chinese Patients

Sequence Characterization of RET in 117 Chinese Hirschsprung Disease Families Identifies a Large Burden of De Novo and Parental Mosaic Mutations

RET Compound Inheritance in Chinese Patients with Hirschsprung Disease: Lack of Penetrance from Insufficient Gene Dysfunction.

Genetic Analysis of RET , EDNRB , and EDN3 Genes and Three SNPs in MCS + 9.7 in Chinese Patients with Isolated Hirschsprung Disease

RET somatic mutations are underrecognized in Hirschsprung disease

Genetic Variants in RET and Risk of Hirschsprung's Disease in Southeastern Chinese: a Haplotype-Based Analysis

Whole Exome Sequencing Identifies a Novel Pathogenic RET Variant in Hirschsprung Disease

Effects of RET, NRG1 and NRG3 Polymorphisms in a Chinese Population with Hirschsprung Disease

Mutation of RET Gene in Chinese Patients with Hirschsprung’s Disease

Mutation of the RET Proto-Oncogene in Hirschsprung^s Disease

Association Analysis of the RET Proto-Oncogene with Hirschsprung Disease in the Han Chinese Population of Southeastern China

Genetic variants in <i>RET</i>, <i>ARHGEF3</i> and <i>CTNNAL1</i>, and relevant interaction networks, contribute to the risk of Hirschsprung disease

Relationship Between Polymorphisms and Haplotypes of RET Gene and Hirschsprung's Disease

RET S409Y Germline Mutation and Associated Medullary Thyroid Carcinoma.

The interplay of common genetic variants NRG1 rs2439302 and RET rs2435357 increases the risk of developing Hirschsprung's disease

Genome-wide association study identifies NRG1 as a susceptibility locus for Hirschsprung's disease.

The Single Nucleotide Polymorphisms in Smad-interacting Protein 1 Gene Contribute to Its Ectopic Expression and Susceptibility in Hirschsprung's Disease.

Genetic variants in RET, ARHGEF3 and CTNNAL1, and relevant interaction networks, contribute to the risk of Hirschsprung disease

Genome-wide association study of Hirschsprung disease detects a novel low-frequency variant at the RET locus

Variability in proliferative and migratory defects in Hirschsprung disease-associated RET pathogenic variants

A Single RET Mutation in Hirschsprung Disease Induces Intestinal Aganglionosis Via a Dominant-Negative Mechanism